Cibus Global  logo
CBUSCibus Global
Trade CBUS now
Cibus Global  primary media

About Cibus Global

Cibus Global (NASDAQ:CBUS), known for its pioneering work in agriculture technology, focuses on developing plant traits for the agricultural community through gene editing. As a forward-thinking entity, Cibus leverages advanced technologies to address the growing concerns around food security, sustainability, and crop efficiency. Their projects span across a range of staple crops, aiming to improve yield, resistance to pests and diseases, and adaptability to changing climates. The ultimate objective of Cibus is to revolutionize agriculture with non-transgenic gene editing, contributing to safer, more sustainable food production without compromising on the planet's health. Their innovative approach positions them as a key player in the global effort to meet the increasing food demands of a rapidly expanding population.

What is CBUS known for?

Snapshot

Public US
Ownership
2010
Year founded
236
Employees
California, United States
Head office
1 of 2
US Rank
Unknown
Sector
N/A
Sector rank
Loading Map...

Operations

All Locations
United States

Products and/or services of Cibus Global

  • Development of non-transgenic trait products for key crops, enhancing yield, drought tolerance and disease resistance.
  • RTDS technology platform, a faster, precise method of editing plant genomes without introducing foreign DNA.
  • Nutritionally enhanced oilseed crops, offering healthier fatty acid profiles for consumer health.
  • Agronomic trait development in staple crops like rice and wheat to improve nitrogen use efficiency.
  • Advanced breeding technologies for reducing chemical inputs in farming, promoting sustainable agriculture.
  • Custom trait development service for agriculture sector, addressing specific challenges of farmers and industries.

Cibus Global executive team

  • Dr. Peter R. Beetham B.Sc., Ph.D.Co-Founder, Interim CEO, President, COO & Director
  • Mr. Rory Balfour Riggs M.B.A.Co-Founder & Director
  • Mr. Cornelis Broos M.Sc.Chief Financial Officer
  • Dr. Gregory F. Gocal Ph.D.Co-Founder, Chief Scientific Officer & Executive VP
  • Mr. Jason Stokes J.D.Chief Administrative Officer, General Counsel & Corporate Secretary
  • Ms. Rosa Cheuk Kim J.D.Senior Vice President of Legal
  • Dr. James Radtke Ph.D.Senior Vice President of Product Development
  • Mr. Sean O'Connor Ph.D.Senior Vice President of Sustainable Ingredients
  • Mr. Tony MoranSenior Vice President of International Development
  • Ms. Noel Sauer Ph.D.Senior Vice President of Research

Connect with us

Disclaimer

Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relate to your unique circumstances.

Grafa is not liable for any loss caused, whether due to negligence or otherwise arising from the use of or reliance on the information provided directly or indirectly, by use of this platform.